Anticholinergic drugs are used in Ophthalmology because they produce what effect?

Choice A rationale

Working with animals is typically done in preclinical trials before phase I studies in humans and is not part of phase III drug evaluation studies.

Choice B rationale

Conducting research to determine the effectiveness of the drug is part of phase II studies. Phase III studies focus more on confirming effectiveness, monitoring side effects, and comparing it to commonly used treatments.

Choice C rationale

Monitoring and observing patients closely for adverse effects is a key responsibility in phase III drug evaluation studies. These studies involve a larger patient population to gather comprehensive safety and efficacy data.

Choice D rationale

Choosing appropriate patients to be involved in the study is primarily the responsibility of researchers and clinicians during the earlier phases of drug development, such as phase I and phase II studies.

Choice A rationale

CSF analysis and MRI are crucial in diagnosing multiple sclerosis (MS). CSF may show elevated levels of oligoclonal bands, indicative of immune system activity in the central nervous system. MRI can detect lesions or plaques in the brain and spinal cord, which are characteristic of MS.

Choice B rationale

Serum albumin and CT scan are not standard diagnostic tools for MS. Serum albumin is more relevant to liver function and nutritional status, while CT scans are less sensitive than MRIs in detecting MS lesions.

Choice C rationale

CSF proteins and angiography are not standard tests for diagnosing MS. While CSF protein levels might be altered in MS, angiography is used to visualize blood vessels and is not relevant to MS diagnosis.

Choice D rationale

Serum anti-acetylcholine antibodies and x-rays are not used to diagnose MS. Anti-acetylcholine antibodies are related to myasthenia gravis, and x-rays are not useful for visualizing MS lesions.